Hu-Lu-Ba-Wan Attenuates Diabetic Nephropathy in Type 2 Diabetic Rats through PKC-α/NADPH Oxidase Signaling Pathway

Table 2

The effect of HLBW on OGTT in rats with DN.

Group	FBG (mmol/L)	PG-1 h (mmol/L)	PG-2 h (mmol/L)
Control	5.84±0.55	6.15±0.37	6.05±0.60
Diabetic	15.81±1.99^△△	27.10±4.52^△△	23.29±3.77^△△
TFG	5.76±0.44^▴▴	10.11±2.97^▴▴	6.51±1.32^▴▴
PC	5.75±1.30^▴▴	9.81±3.71^▴▴	6.26±1.13^▴▴
HLBW	5.73±1.01^▴▴	8.08±0.91^▴▴	6.01±0.91^▴▴
Captopril	8.50±1.58^▴▴	14.90±5.78^▴▴	9.84±1.64^▴▴

Values are mean ± SD (𝑛=8). ^△△𝑃<0.01 versus the control group, ^▴▴𝑃<0.01 versus the untreated diabetic group. FBG: fasting blood glucose; PG-1 h: postprandial blood glucose at 1 hour after glucose loading; PG-2 h: postprandial blood glucose at 2 hours after glucose loading.